Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04452513 · ClinicalTrials.gov registry record
A Prospective Clinical Study of Phenylketonuria (PKU)
A clinical trial, sponsored by BioMarin Pharmaceutical.
- Completed
- Registry status
- 32
- Enrollment target
NCT04452513 is a clinical trial that has completed, run by BioMarin Pharmaceutical. The registered enrollment target is 32 participants.
The verdict
NCT04452513 has completed, sponsored by BioMarin Pharmaceutical.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This is a study for adults and children ≥ 14 years old who have Phenylketonuria (PKU) with uncontrolled plasma Phe levels. No clinical intervention or study drug is provided by BioMarin in this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2022-06-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04452513
The ClinicalTrials.gov registry entry for NCT04452513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMarin Pharmaceutical, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04452513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04452513 about?
NCT04452513 is a clinical study titled "A Prospective Clinical Study of Phenylketonuria (PKU)". This is a study for adults and children ≥ 14 years old who have Phenylketonuria (PKU) with uncontrolled plasma Phe levels. No clinical intervention or study drug is provided by BioMarin in this study.
What is the current status of trial NCT04452513?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2019-10-11. Estimated completion is 2022-06-02.
Who is sponsoring clinical trial NCT04452513?
This trial is sponsored by BioMarin Pharmaceutical, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.